In this episode, AJEM speaks with Heike Schön, Co-founder and Managing Director of Berlin-based Lumis International, about conducting medical cannabis clinical trials in Europe.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Uwe Blesching, PhD, Co-Founder and Chief Science Officer at CannaKeys, an app and online platform that he designed to demystify the science of the endocannabinoid system.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Miri Ogintz, RN, Director of the Cannabis Clinic at Rambam Hospital in Haifa, Israel, who is seeing an increase in mental health symptoms and a high demand for medical cannabis.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Silviu Brill, MD, Director of the Pain Institute at Tel Aviv Sourasky Medical Center and co-organizer of the the 4th International Annual Congress on Controversies on Cannabis-Based Medicines, which took place in Frankfurt, Germany Medical Cannabis.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Michelle Roche, PhD, BSc, MSc, an Associate Professor and Neuroscientist in Physiology at the University of Galway on Ireland’s west coast, about the endocannabinoid system and autism spectrum disorder.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Sara Jane Ward, PhD, Associate Professor at the Center for Substance Abuse Research at Temple University’s Lewis Katz School of Medicine in Philadelphia, Pennsylvania, about the research she conducts on cannabinoid-based therapies for pain.

Visit us at endocannabinoidmedicine.com

In this episode, AJEM's Senior Managing Editor and Brand Director speak with attorney Eric
Postow about cannabis law and the SAFER Banking Act.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM speaks with Henrik Jungaberle, Dr. sc. hum., Executive Director of the Berlin, Germany-based MIND Foundation about how psychedelic medicine is finally gaining acceptance in the mainstream medical community. He discusses how we are still recovering from the 1960's narrative of ‘seeing psychedelics as super-therapy’ and advocates for well-trained therapists who can see both the pitfalls and potential of psychedelic medicine.   

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com

In this episode, AJEM talks with Hinanit Koltai, PhD, a Senior Research Scientist at Israel’s Volcani Institute, about her research showing the potential of cannabinoid-based therapy for the treatment of ovarian cancer.

Visit us at endocannabinoidmedicine.com

Visit us at endocannabinoidmedicine.com